Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Welichem Biotech Inc. is a publicly-traded biotechnology company developing therapeutic drugs in the fields of autoimmune diseases and cancer. ( www.welichem.com )
Welichem Biotech Inc.
316-4475 Wayburne Drive
Burnaby, British Columbia V5G 3L1
Canada
Tel: (604) 432-1703
Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Founded in 2000, Protiva Biotherapeutics Inc. is focused on the development of nucleic acid based pharmaceutical products to fight serious human diseases, such as cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. Validated in human clinical trials, Protiva’s proprietary Stable Nucleic-Acid Lipid Particle (SNALP) technology is an encapsulation and delivery system for nucleic acid payloads, such as short interfering RNA (siRNA), aptamers, and plasmid DNA, to target cells. It represents a breakthrough in the field of RNA interference. On July 13, 2006, Protiva announced the successful completion of a convertible debenture financing with commitments of CAD$5.6 ( www.protivabio.com )
Protiva Biotherapeutics Inc.
100-3480 Gilmore Way
Burnaby, British Columbia V5G 4Y1
Canada
Tel: (604) 630-5061
Fax: (604) 630-5103
Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
PerOs Systems Technologies Inc. is a biotechnology company that develops efficient non-encapsulation strategies to provide oral administration of bioactive compounds (peptides, vaccines, antibodies, etc.). The company was set up in Canada in early 2000 by Denis Bernier and Dr. Grant Vandenberg after a revolutionary discovery that permits the oral delivery of therapeutic molecules including vaccines, peptides and nutraceuticals. PerOs’ patented technology, OraljectTM, will revolutionize the drug delivery system industry by providing key advantages, very low-cost delivery system and an effective large molecule delivery ( www.perosbio.com )
PerOs Systems Technologies Inc.
788 Methot Blvd
St-Nicolas, Quebec G7A 3W4
Canada
Tel: (418) 831-0118
Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
PharmaGap Inc. (TSX-V: GAP), based in Ottawa, ON, is a biotechnology company with a core focus on developing novel therapeutic compounds for the treatment of cancer. PharmaGap’s research platform targets cellular signalling pathways controlled by Protein Kinase C (PKC) isoforms. PharmaGap’s lead drug compound, PhGalpha1, is in preclinical development and targets PKC alpha. The Company has a pipeline of compounds in the design stage which are selective inhibitors of other isoforms of PKC. The Company’s strategy is to out-license drug compounds to larger life sciences companies at the preclinical stage. ( www.pharmagap.com )
PharmaGap Inc.
100 Sussex Drive
Ottawa, Ontario K1A 0R6
Canada
Tel: (613) 998-3400
Fax: (613) 998-3399
Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Affinium is a pharmaceutical company focused on the clinical development of antibacterials. Our lead development program encompasses a potent, orally available, novel antibiotic class for the treatment of antibiotic resistant staphylococcal infections. For information, please contact: Owen Roberts, CFA, Chief Financial Officer Affinium Pharmaceuticals, Inc. 100 University Avenue, 10th Floor, South Tower Toronto, Ontario, Canada ( www.afnm.com )
Affinium Pharmaceuticals Inc.
100 University Avenue, 10Th Floor, South Tower
Toronto, Ontario M5J 1V6
Canada
Tel: (416) 645-6600
Fax: (416) 598-9849
Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
We are a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address treatment resistance in cancer patients. Our product candidates are being developed to block the production of specific proteins associated with the development of treatment resistance, which we believe will increase survival time and improve the quality of life for cancer patients. In response to many cancer therapies (including hormone ablation therapy, chemotherapy and radiation therapy), tumor cells become stressed and increase production of certain proteins. These proteins cause tumor cells to become resistant to the cancer therapies and promote the survival of tumor ( www.oncogenex.ca )
OncoGenex Technologies Inc.
Suite 400 1001 West Broadway
Vancouver, British Columbia V6H 4B1
Canada
Tel: (604) 736-3678
Fax: (604) 736-3687
Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Founded in 1997 as RedCell Inc., ConjuChem Biotechnologies Inc. (“ConjuChem” or the “Company”) is a publicly traded Canadian biotechnology company dedicated to the discovery of novel therapeutics with an initial focus on diabetes. ConjuChem is currently managing several research programs in-house and has one product in clinical development. We are focused on discovering and developing new drugs based on our novel technology platforms called Drug Affinity Complex (DACÔ) and Preformed Conjugate-Drug Affinity Complex (PC-DACÔ). When applied to a compound, DACÔ or PC-DACÔ can create a new drug with similar therapeutic activity but a significantly longer duration of activity in the ( www.conjuchem.com )
ConjuChem Inc.
225 Avenue President Kennedy
Montréal, Quebec H3X 3Y8
Canada
Tel: (514) 844-5558
Fax: (514) 844-1119
Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
INEX is a Canadian biopharmaceutical company developing and commercializing proprietary drugs and drug delivery systems to improve the treatment of cancer. ( www.inexpharm.com )
Inex Pharmaceuticals Corporation
100-8900 Glenlyon Parkway
Burnaby, British Columbia V5J 5J8
Canada
Tel: (604) 419-3200
Fax: (604) 419-3201
Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
PART I ITEM 1. BUSINESS With the exception of historical facts stated herein, the following discussion may contain forward-looking statements regarding events and financial trends that may affect Dragon Pharmaceutical Inc.’s future operating results and financial position. Such statements are subject to risks and uncertainties that could cause Dragon Pharmaceutical Inc.’s actual results and financial position to differ materially from those anticipated in such forward-looking state… ( www.dragonpharmaceuticals.com )
Dragon Pharmaceutical Inc.
1900 – 1055 West Hastings Street
Vancouver, British Columbia V6E 2E9
Canada
Tel: (604) 669-8817
Fax: (604) 669-4243
Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical’s lead technology, MBP8298, is for the treatment of multiple sclerosis and is currently in a pivotal phase II/III clinical trial across Canada and Europe. ( www.biomsmedical.com )
BioMS Medical Corp.
6030-88 Street
Edmonton, Alberta T6E 6G4
Canada
Tel: (780) 413-7152
Fax: (780) 466-6791